Ultrasound-Guided Breast Biopsy Market Global Industry Analysis, size, share -

Posted by Shirish Wadaskar on August 13th, 2019

Ultrasound-Guided Breast Biopsy: Market Insights

Breast cancer is one of the leading cause of cancer in women affecting nearly 80% of women over 50 years of age. Breast cancer mostly starts either with the breast tissue which is made up of glands for milk production know as lobules or in the ducts. Abnormalities or lumps in breast are mostly detected by mammography or physical examination and other imaging techniques. Thus, ultrasound-guided breast biopsy was introduced into the market which is performed by taking some abnormality samples by guidance from MRI or mammography, ultrasound. In ultrasound-guided breast biopsy, radiologist used ultrasound imaging to guide to the site of abnormal growth of the cells. An ultrasound-guided breast biopsy is mostly performed when there occurs an abnormality such as distortion in the structure of the breast tissue, suspicious mass of solid and area of change of abnormal tissue. According to World Health Organization, an estimate of 627,000 women died from breast cancer in 2018 globally. Thus with increasing prevalence of breast cancer, ultrasound-guided breast biopsy is likely to spur the growth of the market.

Download Sample of Report with important Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9580

Ultrasound-Guided Breast Biopsy: Market Dynamics

Ultrasound-guided breast biopsy is expected to manifest significant growth in the market due to its less invasive than other surgical biopsy. In addition to this, ultrasound-guided breast biopsy leaves little scar and can be performed in in very less time which as a result will increase the adoption rate of ultrasound-guided breast biopsy. Apart from this, no ionizing radiation is used in ultrasound-guided breast biopsy imaging and also provide faster results which is likely to drive the growth of the ultrasound-guided breast biopsy market. Moreover the ultrasound-guided breast biopsy is less expensive and has less recovery time. All this factor will contribute to the growth of the ultrasound-guided breast biopsy market. However, there are certain limitation in restraining the growth of the ultrasound-guided breast biopsy market. Certain factors such as risk of bleeding that forms hematoma may appear during biopsy. In addition to this, patients may find discomfort during the biopsy which in turn may affect the growth of the ultrasound-guided breast biopsy market. Cost of instrument is also another important factor in restraining the growth of the market.

Ultrasound-Guided Breast Biopsy Market: Segmentation